Recent studies reveal MG53 (TRIM72) enhances muscle stem cell activation and reduces inflammation, offering a novel therapeutic target for sarcopenia with promising preclinical and early clinical resu...
Recent research reveals ferroptosis, an iron-dependent cell death mechanism, as a key factor in age-related muscle loss, with potential therapies targeting lipid peroxidation. A 2023 study in ‘A...
Recent research indicates that upregulating CMA via LAMP2A can reverse muscle atrophy in aging, with potential for new interventions against sarcopenia. Scientists discover CMA enhancement as a key to...